118 related articles for article (PubMed ID: 3960887)
1. ICPEMC perspectives on the scientific basis of risk assessment in genetic toxicology.
Bridges BA
Prog Clin Biol Res; 1986; 208():175-82. PubMed ID: 3960887
[No Abstract] [Full Text] [Related]
2. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC publication no. 6: do treatments available for psoriasis patients carry a genetic or carcinogenic risk?
Mutat Res; 1981 May; 86(3):279-304. PubMed ID: 7029262
[No Abstract] [Full Text] [Related]
3. The complementary roles of in vitro and in vivo tests in genetic toxicology assessment.
Kluwe WM
Regul Toxicol Pharmacol; 1995 Dec; 22(3):268-72. PubMed ID: 8837851
[TBL] [Abstract][Full Text] [Related]
4. ICPEMC to help protect against genetic diseases and cancer.
WHO Chron; 1978 Oct; 32(10):400-1. PubMed ID: 716383
[No Abstract] [Full Text] [Related]
5. Genetic toxicology at the crossroads--a personal view on the deployment of short-term tests for predicting carcinogenicity.
Bridges BA
Mutat Res; 1988; 205(1-4):25-31. PubMed ID: 3367919
[No Abstract] [Full Text] [Related]
6. The expanding role of predictive toxicology: an update on the (Q)SAR models for mutagens and carcinogens.
Benigni R; Netzeva TI; Benfenati E; Bossa C; Franke R; Helma C; Hulzebos E; Marchant C; Richard A; Woo YT; Yang C
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(1):53-97. PubMed ID: 17365342
[TBL] [Abstract][Full Text] [Related]
7. IPCS harmonization of methods for the prediction and quantification of human carcinogenic/mutagenic hazard, and for indicating the probable mechanism of action of carcinogens.
Ashby J; Waters MD; Preston J; Adler ID; Douglas GR; Fielder R; Shelby MD; Anderson D; Sofuni T; Gopalan HN; Becking G; Sonich-Mullin C
Mutat Res; 1996 Jun; 352(1-2):153-7. PubMed ID: 8676904
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the carcinogenicity and mutagenicity of chemicals. Report of a WHO Scientific Group.
World Health Organ Tech Rep Ser; 1974; 546(0):1-19. PubMed ID: 4214379
[No Abstract] [Full Text] [Related]
9. 11th Alexander Hollaender course in genetic toxicology University of Bío-Bío, Concepcion, Chile,October 2006. Preface.
Zamorano-Ponce E
Mutat Res; 2008; 658(3):153. PubMed ID: 18456543
[No Abstract] [Full Text] [Related]
10. An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.
McCarroll N; Keshava N; Cimino M; Chu M; Dearfield K; Keshava C; Kligerman A; Owen R; Protzel A; Putzrath R; Schoeny R
Environ Mol Mutagen; 2008 Mar; 49(2):117-31. PubMed ID: 18240158
[TBL] [Abstract][Full Text] [Related]
11. Mutagenicity testing for chemical risk assessment: update of the WHO/IPCS Harmonized Scheme.
Eastmond DA; Hartwig A; Anderson D; Anwar WA; Cimino MC; Dobrev I; Douglas GR; Nohmi T; Phillips DH; Vickers C
Mutagenesis; 2009 Jul; 24(4):341-9. PubMed ID: 19535363
[TBL] [Abstract][Full Text] [Related]
12. Chemical structure of mutagens and carcinogens and the relationship with biological activity.
Benigni R
J Exp Clin Cancer Res; 2004 Mar; 23(1):5-8. PubMed ID: 15149144
[TBL] [Abstract][Full Text] [Related]
13. Short-term tests for defining mutagenic carcinogens.
Waters MD; Stack HF; Jackson MA
IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
[TBL] [Abstract][Full Text] [Related]
14. Use of genetic toxicology information for risk assessment.
Dearfield KL; Moore MM
Environ Mol Mutagen; 2005 Dec; 46(4):236-45. PubMed ID: 16258925
[TBL] [Abstract][Full Text] [Related]
15. Validation issues for the use of transgenic mouse mutation assays in risk assessment.
Gorelick NJ
Prog Clin Biol Res; 1996; 395():81-108. PubMed ID: 8895985
[No Abstract] [Full Text] [Related]
16. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 18. Review of the genotoxicity and carcinogenicity of antischistosomal drugs; is there a case for a study of mutation epidemiology? Report of a task group on mutagenic antischistosomals.
Kramers PG; Gentile JM; Gryseels BJ; Jordan P; Katz N; Mott KE; Mulvihill JJ; Seed JL; Frohberg H
Mutat Res; 1991 Jan; 257(1):49-89. PubMed ID: 1987457
[TBL] [Abstract][Full Text] [Related]
17. Guidelines for the testing of chemical for mutagenicity. Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment.
Rep Health Soc Subj (Lond); 1981; 24():1-95. PubMed ID: 7244358
[No Abstract] [Full Text] [Related]
18. Development of genetic toxicology in the Philippines: problems and perspectives.
Lim-Sylianco CY
Prog Clin Biol Res; 1986; 209B():295-300. PubMed ID: 3749087
[No Abstract] [Full Text] [Related]
19. Comparison of carcinogenic and in vivo genotoxic potency estimates.
Sanner T; Dybing E
Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
[TBL] [Abstract][Full Text] [Related]
20. Genetic toxicology perspectives in Latin America.
de Nava CC; Maffey L
Prog Clin Biol Res; 1986; 209B():301-5. PubMed ID: 3749089
[No Abstract] [Full Text] [Related]
[Next] [New Search]
